Hochschulschrift
Expressionsanalyse von Tumorprogressionsmarkern im Pankreaskarzinom am Beispiel von CD24, PLK-1 und PPAR-ã
- Alternative title
-
Expression of tumor progession marker in adenocarcinomas of the pancreas using the example of CD24, PLK1 and PPAR-ã
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Diss., 2008
- Classification
-
Medizin, Gesundheit
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (when)
-
2008
- Creator
-
Jacob, Juliane
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000003590-3
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Jacob, Juliane
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Time of origin
- 2008
Other Objects (12)
![RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
Virtuelles Screening und De-Novo-Design von PPARα-Agonisten [PPAR-alpha-Agonisten] mit Oberflächen-Deskriptoren
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Synthese und in-vitro-pharmakologische Charakterisierung von dualen PPARα/γ-Agonisten [PPAR-alpha-gamma-Agonisten]
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Einfluss der Weichmachermetaboliten Monoethylhexyl-Phthalat (MEHP) und 4-Heptanon auf die Transkriptionsfaktoren PPARα [PPAR-alpha] und PPARγ [PPAR-gamma] in humanen Leber- und Endothelzellen
Genetic and diet effects on Ppar-α and Ppar-γ signaling pathways in the Berlin Fat Mouse Inbred line with genetic predisposition for obesity
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
Virtuelles Screening und De-Novo-Design von PPARα-Agonisten [PPAR-alpha-Agonisten] mit Oberflächen-Deskriptoren
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Synthese und in-vitro-pharmakologische Charakterisierung von dualen PPARα/γ-Agonisten [PPAR-alpha-gamma-Agonisten]
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Einfluss der Weichmachermetaboliten Monoethylhexyl-Phthalat (MEHP) und 4-Heptanon auf die Transkriptionsfaktoren PPARα [PPAR-alpha] und PPARγ [PPAR-gamma] in humanen Leber- und Endothelzellen
Genetic and diet effects on Ppar-α and Ppar-γ signaling pathways in the Berlin Fat Mouse Inbred line with genetic predisposition for obesity
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
Role of peroxisome proliferator activated receptor α [alpha] (PPARα) [PPAR-alpha] in cardiomyogenesis of mouse embryonic stem cells
RAGE dependent regulation of PPAR-α [PPAR-alpha] in bone metabolism
RAGE-deficiency results in reduced PPAR-α [PPAR-alpha] nuclear translocation, proinflammation and altered bone metabolism
Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
Virtuelles Screening und De-Novo-Design von PPARα-Agonisten [PPAR-alpha-Agonisten] mit Oberflächen-Deskriptoren
Modulation inflammatorischer Atherosklerosemarker durch Peroxisome proliferator-activated receptor-alpha (PPARα)]-aktivierendes [(PPAR-alpha)-aktivierendes] Fenofibrat
Synthese und in-vitro-pharmakologische Charakterisierung von dualen PPARα/γ-Agonisten [PPAR-alpha-gamma-Agonisten]
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
Einfluss der Weichmachermetaboliten Monoethylhexyl-Phthalat (MEHP) und 4-Heptanon auf die Transkriptionsfaktoren PPARα [PPAR-alpha] und PPARγ [PPAR-gamma] in humanen Leber- und Endothelzellen
Genetic and diet effects on Ppar-α and Ppar-γ signaling pathways in the Berlin Fat Mouse Inbred line with genetic predisposition for obesity
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone